Tremfya launched for psoriasis
Pharmacy Magazine,
03 Jan 2018
1 Min
Tremfya launched for psoriasis
Pharmacy Magazine,
03 Jan 20181 Min
In Clinical
Follow this topic
Bookmark
Record learning outcomes
Janssen has launched guselkumab (Tremfya) for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy. Janssen says that guselkumab is the first biologic to €selectively target interleukin-23, a key protein that initiates a specific immune inflammatory response€.
Copy Link
Record my learning outcomes
Save for later
In Clinical
Let’s get clinical. Follow the links below to find out more about the latest clinical insight in community pharmacy.